Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. G. Stoica, D. Pana (Bucharest, Romania). Markers of asthma outcome. Eur Respir J 2007; 30: Suppl. 51, 282

Member's Comments

No comment yet.

Related content which might interest you: Clinical markers of asthma outcome in adolescents Source: Eur Respir J 2006; 28: Suppl. 50, 254s Year: 2006 Assessment of predictive factors for asthma exacerbations severity Source: Eur Respir J 2006; 28: Suppl. 50, 503s Year: 2006 Outcome of childhood asthma Source: Eur Respir J 2005; 26: Suppl. 49, 451s Year: 2005 Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Predictors of exacerbations in asthma Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Risk factors for asthma exacerbations: is severity a predictor? Source: Annual Congress 2003 - Burden of asthma Year: 2003 Markers of severity and inflammatory profile during exacerbations of severe asthma. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 Inflammatory biomarkers in the evaluation of two-year  outcomes  of omalizumab treatment in severe allergic asthma. Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018 Efficacy of omalizumab in allergic asthma by asthma severity and eosinophilic status Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 Factors associated with poor prognostic outcome in acute exacerbation of COPD Source: Annual Congress 2009 - Treatment of airways disease Year: 2009 Role of biomarkers in the assessment and phenotyping asthma and COPD Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Club Cell Protein-16 modifies airway inflammation in asthma and is associated with significant clinical asthma outcomes Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 Markers of early disease and prognosis in COPD Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009 Features of FeNO-high asthma phenotype Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001 Severe outcomes of COVID-19 among patients with COPD and asthma Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020 Year: 2021 Allergen specific immunotherapy: Effect on immunological markers and clinical outcomes in asthmatic children Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016